Latest News

Argentum Medical gets $8.4M BARDA contract for silver-plated antimicrobial dressings

Argentum Medical announced that it has been awarded a 3-year, $8.4 million contract with the Biomedical Advanced Research and Developmental Authority, or BARDA, to repurpose its commercial Silverlon technology for skin injuries occurring during radiological and nuclear emergencies.
According to the company, the contract will cover the examination of potential uses of the silver-plated antimicrobial dressings in treating low-grade and severe skin radiation after a radiation emergency.
Argentum also announced that it is nearing completion of studies required to apply for an FDA clearance for

Source link

Related posts

Innovative hub feeds the need for fresh produce in flint


Biodiversity and the built environment: Implications for the Sustainable Development Goals (SDGs)


Study shows brain can be tricked into thinking body is working harder than it is


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World